IQVIA Holdings

IQV · NYSE

$267.85+$1.97 (+0.74%)TodayMarket closed · Oct 20, 7:58 PM ET

Prev close $265.88

About IQV

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.

Employees: 93,000
Headquarters: Durham, North Carolina
Listed: May 9, 2013
Sector: Health Care
Industry: Life Sciences Tools & Services
Website: ir.iqvia.com

Leadership

IQVIA Holdings executives
Name	Title	Since	Age
Ari Bousbib	—	2016	64
Michael Fedock	—	—	51
Alistair Grenfell	—	—	52
Bhavik Patel	—	—	46
Walter Staub	—	—	63
Eric Sherbet	—	—	61
James Berkshire	—	—	52
Bernd Haas	—	—	50
John Leonard	—	—	68
Carol Burt	—	—	68
John Danhakl	—	—	69
James Fasano	—	—	56
Colleen Goggins	—	—	71
William Kaelin	—	—	68
Leslie Morris	—	—	55
Todd Sisitsky	—	—	53
Sheila Stamps	—	—	68
Kerri Joseph	—	2024	—

Revenue by product and region

Fiscal year ended Dec 31, 2025: $16.31B total revenue

By product

Research & Development Solutions$8.90B54.5%
Technology & Analytics Solutions$6.63B40.6%
Contract Sales & Medical Solutions$788.00M4.8%

By region

Americas$7.75B47.5%
Europe and Africa$5.18B31.8%
Asia-Pacific$3.38B20.7%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

IQVIA Holdings suppliers and customers
Company	Relationship	Country	Correlation
Catalent, Inc. CTLT	Supplier	US	0.74
Quest Diagnostics DGX	Supplier and customer	US	0.74
BrainPad	Supplier and customer	JP	0.56
Dimerix DXB.AX	Customer	AU	0.56
Betta Pharmaceuticals Co., Ltd.	Customer	CN	0.43
Eutilex	Customer	KR	0.32
Acrux ACR.AX	Supplier and customer	AU	0.30
Vericel Corporation VCEL	Customer	US	0.21
Medical Data Vision	Supplier and customer	JP	0.21
NRX Pharmaceuticals NRXP	Supplier and customer	US	0.19

Similar companies

Companies in the same industry as IQVIA Holdings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.